Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1)

Blood

Volumn 94, Issue 1, 1999, Pages 251-259

  Chen, Yi Hsiang ^a   Lavelle, Donald ^a   DeSimone, Joseph ^a   Uddin, Shahab ^a   Platanias, Leonidas C ^a   Hankewych, Maria ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; INTERLEUKIN 6 RECEPTOR; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; DRUG EFFECT; EXPRESSION VECTOR; HUMAN; HUMAN CELL; MYELOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

EID: 0033168314     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.1.251.413k42_251_259     Document Type: Article

References (38)

1. Chen Y-H, Desai P, Shiao R-T, Lavelle D, Haleem A, Chen J: Inhibition of myeloma cell growth by dexamethasone and all-trans retinoic acid: Synergy through modulation of interleukin-6 autocrine loop at multiple sites. Blood 87:314, 1996
2. Sidell N, Taga T, Hirano T, Kishimoto T, Saxon A: Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 146:3809, 1991
3. Ogata A, Nishimoto N, Shima Y, Yoshizaki K, Kishimoto T: Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 84:3040, 1994
4. Levy Y, Labaume S, Colombel M, Brouet JC: Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis. Clin Exp Immunol 104:167, 1996
5. Ishikawa H, Tanaka H, Iwato K, Tanabe O, Asaoku H, Nobuyoshi M, Yamamoto I, Kawano M, Kuramoto A: Effect of glucocorticoids on the biologic activities of myeloma cells: Inhibition of interleukin-1β osteoclast activating factor-induced bone resorption. Blood 75:715, 1990
6. Shiao R-T, Mcleskey SB, Khera SY, Wolfson A, Freter CE: Mechanisms of inhibition of IL-6-mediated immunoglobulin secretion by dexamethasone and suramin in human lymphoid and myeloma cell lines. Leuk Lymphoma 21:293, 1996
7. Klein B, Zhang X-G, Lu Z-Y, Bataille R: Interleukin-6 in human multiple myeloma. Blood 85:863, 1995
8. Suzuki H, Yasukawa K, Saito T, Goitsuka R, Hasegawa A, Ohsugi Y, Taga T, Kishimoto T: Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo. Eur J Immunol 22:1989, 1992
9. Demartis A, Bernassola F, Savino R, Melino G, Ciliberto G: Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death. Cancer Res 56:4213, 1996
10. Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T: Cloning and expression of the human interleukin-6 (BSF/IFNb 2) receptor. Science 241:825, 1988
11. Uddin S, Yenush L, Sun X-J, Sweet ME, White MF, Platanias LC: Interferon α engages the insulin receptor substrate-1 to associate with the phosphotidylinositol 3'-kinase. J Biol Chem 270:1538, 1995
12. Uddin S, Fish EN, Sher D, Gardziola C, Colamonici OR, Kellum M, Pitha PM, White MF, Platanias LC: The IRS-pathway operates distinctively from the stat-pathway in hematopoietic cells and transduces common and distinct signals during engagement of the insulin or interferon-a receptors. Blood 90:2574, 1997
13. Heieren MH, Kim YK, Balfour JJ Jr: Human cytomegalovirus infection of kidney glomerular visceral epithelial and tubular epithelial cells in culture. Transplantation 46:426, 1988
14. Murakami M, Hibi M, Nakagawa N, Nakagawa T, Yasukawa K, Hamaguchi M, Taga T, Kishimoto T: Interleukin-6 induced homodimerization of gp130 and associated activation of a tyrosine kinase. Science 260:1808, 1993
15. Urashima M, Ogata A, Chauhan K, Vidriales MB, Teoh G, Hoshi Y, Schlossman RL, DeCarpio JA, Anderson KC: Interleukin-6 promotes multiple myeloma cell growth via phosphorylation of retinoblastoma protein. Blood 88:2219, 1996
16. WAF1 and dephosphorylation of retinoblastoma protein. Leuk Lymphoma 1999 (in press)
17. Hirano T, Hakajima K, Hibi M: Signaling mechanisms through gp130: A model of the cytokine system. Cytokine Growth Factor Rev 8:241, 1997
18. Urashima M, Teoh G, Chauhan D, Hoshi Y, Ogata A, Treon P, Schlossman RL, Anderson KC: Interleukin-6 overcomes p21WAF1 upregulation and G1 growth arrest induced by dexamethasone and Interferon-γ in multiple myeloma cells. Blood 90:279, 1997
19. Liu M, Iavarone A, Freedman LP: Transcriptional activation of the human p21WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 271:31723, 1996
20. Matikainen S, Ronni T, Lehtonen A, Sareneva T, Melen K, Nordin S, Levy DE, Julkunen I: Retinoic acid induces signal transducers and activator of transcription (STST) 1, STAT2, and p48 expression in myeloid leukemia cells and enhances their responsiveness to interferons. Cell Growth Differ 8:687, 1997
21. Gianni M, Terao M, Fortino I, LiGalzi M, Viggiano V, Barbui T, Rambaldi A, Garanttini E: Stat 1 is induced and activated by all-trans retinoic acid in acute promyelocytic leukemia cells. Blood 89:1001, 1997
22. Kola V, Linder DJ, Weihua X, Borden EC, Kalvakolanu DJ: Modulation of interferon (INF)-inducible gene expression by retinoic acid. J Biol Chem 271:10508, 1996
23. WAF1/CIP1 mediated by STST1. Science 272:719, 1996
24. Chen Y-H, Shiao R-T, Labayog J-M, Modi S, Lavelle D: Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma. Leuk Lymphoma 27:11, 1997
25. Hallek M, Bergsagel L, Anderson K: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3, 1998
26. Gudas LJ, Sporn MB, Roberts AB: Cellular biology and biochemistry of the retinoids, in Sporn MB, Roberts AB, Goodman DS (eds): The Retinoids: Biology, Chemistry, and Medicine (ed 2). New York, NY, Raven, 1994, p443
27. Zheng ZS, Goldsmith LA: Modulation of epidermal growth factor receptors by retinoic acid in ME 180 cells. Cancer Res 50:1201, 1990
28. Zheng ZS, Polakowska R, Johnson A, Goldsmith LA: Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ 3:225, 1992
29. Steck PA, Hadi A, Lotan R, Yung WKA: Inhibition of epidermal growth factor receptor activity by retinoic acid in glioma cells. J Cell Biochem 42:83, 1990
30. Rizzino A: Appearance of high-affinity receptors for type beta transforming growth factor during differentiation of murine embryonal carcinoma cells. Cancer Res 47:4386, 1987
31. Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ: Induction of transforming growth factor β1 and its receptors during all-trans-retinoic acid (RA) treatment of RA responsive human neuroblastoma cell lines. Cancer Res 55:2380, 1995
32. Falk LA, DeBenedetti F, Lohrey N, Birchenall-Roberts MC, Ellingsworth LW, Faltynek CR, Ruscetti FW: Induction of transforming growth factor-beta 1 (TGF-beta 1), receptor expression and TGF-beta-1 protein production in retinoic acid-treated HL-60 cells: Possible TGF-beta-1-mediated autocrine inhibition. Blood 77:1248, 1991
33. Jacobsen SEW, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR: Transforming growth factor-β trans-modulate the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 77:1706, 1991
34. Wang D, Yang EB, Cheng LY: Modulation of EGF receptor by tumor necrosis factor-alpha in human hepatocellular carcinoma HepG2 cells. Anticancer Res 16:3001, 1996
35. Baccarini M, Dello Sbarba P, Buescher D, Bartocci A, Stanley ER: INF-γ/lipopolysaccharide activation of macrophage is associated with protein kinase C-dependent down-regulation of colony-stimulating factor 1 receptor. J Immunol 149:2656, 1992
36. Dello Sbarba P, Nencioni L, Labardi D, Rorida E, Cacciagli B, Cipolleschi MG: Interleukin-2 down-regulates the macrophage colony stimulating factor receptor in murine macrophage. Cytokine 8:488, 1996
37. Kim IY, Zelner DJ, Sensibar JA, Ahn HJ, Park L, Kim JH, Lee C: Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone. Exp Cell Res 222:103, 1996
38. Sporn MS, Roberts AB: Autocrine secretion - 10 years later. Ann Intern Med 117:408, 1992